Search results
Results From The WOW.Com Content Network
The reaction of boron trichloride with alcohols was reported in 1931, and was used to prepare dimethoxyboron chloride, B(OCH 3) 2 Cl. [3] Egon Wiberg and Wilhelm Ruschmann used it to prepare tetrahydroxydiboron by first introducing the boron–boron bond by reduction with sodium and then hydrolysing the resulting tetramethoxydiboron, B 2 (OCH 3) 4, to produce what they termed sub-boric acid. [4]
Some representative reactions showing 1,2-addition of diboron tetrachloride to hydrocarbons. Some of these reactions can also be carried out under more forcing conditions with diboron tetrafluoride. Tetrahalodiboranes can add to unsaturated hydrocarbons. Schlesinger et al. published 1,2-additions of B 2 Cl 4 to ethylene and acetylene. [16]
Ba(NO 2) 2: barium nitrite: 13465–94–6 Ba(NO 3) 2: barium nitrate: 10022–31–8 BaN 6: barium azide: 18810–58–7 Ba(NbO 3) 2: barium niobate: 12009–14–2 BaO: barium oxide: 1304–28–5 Ba(OH) 2: barium hydroxide: 17194–00–2 BaO 2: barium peroxide: 1304–29–6 Ba(PO 3) 2: barium metaphosphate: 13466–20–1 Ba(ReO 4) 2 ...
Barium borate is an inorganic compound, a borate of barium with a chemical formula BaB 2 O 4 or Ba(BO 2) 2. It is available as a hydrate or dehydrated form, as white powder or colorless crystals. The crystals exist in the high-temperature α phase and low-temperature β phase, abbreviated as BBO ; both phases are birefringent , and BBO is a ...
Boron trioxide or diboron trioxide is the oxide of boron with the formula B 2 O 3. It is a colorless transparent solid, almost always glassy (amorphous), which can be crystallized only with great difficulty.
Download QR code; Print/export Download as PDF ... This is a list of common chemical compounds with chemical formulae and CAS numbers, ... (NO 3) 2: barium nitrate ...
Paramount Plus is currently offering new users a 30-day free trial with a limited-time discount code. Here’s everything you need to know to for claiming the extended Paramount Plus free trial.
MRTX1133 is an investigational drug that targets the G12D mutation in KRAS dependent cancers. [1] [2] It is currently in a phase 1/2 clinical trial for the treatment of solid tumors. [3]